Disclosure Of First-Time Adoption [Text Block]

ERYTECH Pharma S.A. - Filing #2810992

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Comprehensive income
EUR
23 652 EUR
23 488 EUR
EUR
49,000 EUR
213,000 EUR
228,000 EUR
EUR
235,000 EUR
194,000 EUR
EUR
187,000 EUR
53 797 EUR
68,000 EUR
EUR
528,000 EUR
EUR
54 257 EUR
Profit (loss)
23 488 EUR
23 488 EUR
228,000 EUR
228,000 EUR
53 797 EUR
53 797 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.